ArticleJournal of endocrinological investigation2024

Real-world use of oral versus subcutaneous semaglutide in a cohort of type 2 diabetic patients: which option to which patient?

C Formichi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.